Skip to content

Fact Sheet: Ncyte® vCardiomyocytes

Get information on Ncardia’s Ncyte® vCardiomyocytes, high purity and functional cardiomyocytes ideal for discovery and preclinical safety research
DOWNLOAD NOW
Screenshot 2025-04-07 095711

Discover Ncyte® vCardiomyocytes

Human induced pluripotent stem cell (hiPSC)-derived ventricular cardiomyocytes provide a reliable in vitro
system for mechanistic analysis, as well as drug safety and efficacy screenings. This platform
can help improve our understanding of the underlying pathophysiological mechanisms of cardiac
disease and develop effective treatments.


Ncyte® vCardiomyocytes are fully functiona and a clinically relevant cellular model compatible with functional assays such as calcium-imaging, contractility force evaluations, and metabolic studies among others.

 




ABOUT US
Predict future safety and efficacy more efficiently
For more than a decade, Ncardia has been pioneering innovations in human induced pluripotent stem cells (iPSC). Our iPSC drug discovery platforms have been successfully leveraged by large biopharmas, up-and-coming drug discovery firms and multinational research consortia to advance therapeutic candidates for cardiovascular, neurological and other disease areas.

Download the fact sheet by filling out the form below: